ClinicalTrials.gg
Status unknownNCT03422107Updated Mar 12, 2018

Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia

An observational study in Peripheral Nerve Injuries and Thoracic Surgery, sponsored by Western University, Canada. Status unknown at 1 site in Canada. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2018-03-12.

Sponsored by Western University, Canada · Observational

The sponsor has not verified this record recently (last verified Jan 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 95 Years
Sex
All
01

Study summary

PNI (Peripheral Nerve Injury) occurs in 5-15% of patients in cardiac surgery. So far, the mechanism of injury has never been researched. In this study, we will compare minimally invasive cardiac surgery with conventional cardiac surgery using a novel portable SSEP device to pinpoint the mechanism and timing of PNI during cardiac surgery.

Read the detailed description

General objectives The general objective of this study is to identify the causative insults during various kinds of cardiac surgeries. To attain this objective, we have three specific aims. Firstly, surgical insults such as excessive or asymmetric sternal retraction have long been regarded as the main causes of PNI. Therefore, we will investigate this by comparing cardiac surgeries with sternotomy to the ones without sternotomy. Secondly, more and more cardiac surgeons utilize minimally invasive techniques these days. In the current study, we will investigate the incidence, mechanisms and patterns of PNI in minimally invasive cardiac surgeries by comparing conventional surgeries to minimally invasive surgeries. Thirdly, recent studies have suggested systematic insults such as ischemia, inflammation, and underlying neuropathy might play more prominent roles in the mechanism of PNI. In this study, we will analyze various factors such as intraoperative hemodynamics and baseline patient characteristics to pinpoint the most responsible factors.

Background The studies regarding mechanisms of PNI in cardiac surgeries have not been done over the past few decades. With respect to minimally invasive cardiac surgeries, no studies have been done to investigate the mechanism of PNI.

Regarding the device used in this study The conventional SSEP device is large in size, invasive, and requires expertise to interpret. These characteristics have prevented its use in the operating room. This new portable SSEP device is devoid of these properties.

Significance Identification of causative insults will help clinicians to recognize and possibly prevent PNI during cardiac surgeries.

02

Conditions studied

  • Peripheral Nerve Injuries
  • Thoracic Surgery

Keywords

  • Peripheral Nerve Injuries
  • Thoracic Surgery
  • Minimally invasive cardiac surgery
03

In context

Peripheral Nerve Injuries

90 studies on the registry are indexed under Peripheral Nerve Injuries; 24 are open to participants now.

This study's planned enrollment of 100 is above the median of 63 across 24 observational studies indexed under Peripheral Nerve Injuries.

Browse Peripheral Nerve Injuries studies →

Lead sponsor

Western University, Canada is the lead sponsor of 224 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Our inclusion criteria are all adult (age>18 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG. This 4 groups of patients represent 4 different combination of potential surgical insults- median sternotomy, Internal thoracic artery (ITA) retraction, ITA harvesting, cardiopulmonary bypass and positioning

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

●all adult (age>18, \<95 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG

Exclusion criteria

Exclusion Criteria:

  • any patients with to SSEP monitoring, which include skin burns or trauma at SSEP electrode sites
  • lack of written consent
  • emergency surgery
  • language barrier
  • fluctuating neurological signs/symptoms
  • regional anesthesia (spinal, epidural, nerve block)
  • CABG with radial artery harvest, combined cardiac surgeries
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • TAVI

    Transcatheter Aortic Valve Implantation

  • cAVR

    Conventional Valve Replacement

  • rCABG

    minimally invasive coronary artery bypass graft

  • cCABG

    Conventional Coronary Artery Bypass Graft

06

What researchers measure

Primary outcomes

  1. Cumulative duration of abnormal SSEP

    Defined as the amplitude reduction \>50% from baseline, Latency\>10% from baseline

    Time frame: From the beginning of the surgery to the end of surgery

Secondary outcomes

  1. The incidence of postoperative peripheral neuropathy at post-operative day 2-5

    The incidence of postoperative peripheral neuropathy at Post-operative day (POD) 2-5, which is diagnosed based on neurological examination

    Time frame: Post operative day 2 to 5

  2. The number of SSEP abnormal alarms

    The frequencies the SSEP devise sets off alarms

    Time frame: From the beginning of the surgery to the end of surgery

07

Study locations

1 of 1 sites recruiting
  • London Health Sciences Centre
    London, Ontario N6A 5A5, Canada
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2017 (actual). Primary completion is estimated for Dec 2018, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2018
First posted
Feb 5, 2018
StartActual
Nov 20, 2017
Primary completionEst.
Dec 31, 2018
CompletionEst.
Jun 30, 2019
Last update
Mar 12, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03422107
Responsible party
Sponsor
First posted
Feb 5, 2018
Start date
Nov 20, 2017
Primary completion
Dec 31, 2018 (estimated)
Completion
Jun 30, 2019 (estimated)
Last update
Mar 12, 2018

Study contacts

Satoru Fujii, MD
Contact
satoru.fujii@lhsc.on.ca
226-378-2471
John Murkin, MD
study director · Western University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion